These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16302891)

  • 1. Evidence-based treatment of idiopathic generalized epilepsies with new antiepileptic drugs.
    Bergey GK
    Epilepsia; 2005; 46 Suppl 9():161-8. PubMed ID: 16302891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based treatment of idiopathic generalized epilepsies with older antiepileptic drugs.
    Hitiris N; Brodie MJ
    Epilepsia; 2005; 46 Suppl 9():149-53. PubMed ID: 16302889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical management issues for idiopathic generalized epilepsies.
    Benbadis SR
    Epilepsia; 2005; 46 Suppl 9():125-32. PubMed ID: 16302886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seizure aggravation in idiopathic generalized epilepsies.
    Chaves J; Sander JW
    Epilepsia; 2005; 46 Suppl 9():133-9. PubMed ID: 16302887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ;
    Epilepsia; 2004 May; 45(5):410-23. PubMed ID: 15101822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam in the treatment of idiopathic generalized epilepsies.
    Grünewald R
    Epilepsia; 2005; 46 Suppl 9():154-60. PubMed ID: 16302890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy and tolerability of new antiepileptic drugs: what can we learn from long-term studies?
    Zaccara G; Messori A; Cincotta M; Burchini G
    Acta Neurol Scand; 2006 Sep; 114(3):157-68. PubMed ID: 16911343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies.
    Patsalos PN
    Epilepsia; 2005; 46 Suppl 9():140-8. PubMed ID: 16302888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New antiepileptic drugs in childhood epilepsies: indications and limits].
    Kaminska A
    Epileptic Disord; 2001; 3 Spec No 2():SI37-46. PubMed ID: 11827845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discontinuation and duration of antiepileptic drug therapy: a retrospective study of factors for specific epileptic syndromes.
    Kudo T; Nishida T; Yagi K
    Epilepsia; 2004; 45 Suppl 8():26-32. PubMed ID: 15610191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic (primary) generalized epilepsy. Traditional versus new antiepileptic drugs.
    Yadegari S; Bahrami P
    Neurosciences (Riyadh); 2013 Apr; 18(2):117-21. PubMed ID: 23545607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some treatments cause seizure aggravation in idiopathic epilepsies (especially absence epilepsy).
    Somerville ER
    Epilepsia; 2009 Sep; 50 Suppl 8():31-6. PubMed ID: 19702731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectrum of the new antiepileptic drugs.
    Perucca E
    Acta Neurol Belg; 1999 Dec; 99(4):231-8. PubMed ID: 10674140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photosensitivity in idiopathic generalized epilepsies.
    Covanis A
    Epilepsia; 2005; 46 Suppl 9():67-72. PubMed ID: 16302877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ;
    Epilepsia; 2004 May; 45(5):401-9. PubMed ID: 15101821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levetiracetam: preliminary efficacy in generalized seizures.
    Kasteleijn-Nolst Trenité DG; Hirsch E
    Epileptic Disord; 2003 May; 5 Suppl 1():S39-44. PubMed ID: 12915340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of refractory idiopathic epilepsies.
    Perucca E
    Epilepsia; 2001; 42 Suppl 3():31-5. PubMed ID: 11520320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
    Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
    Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New antiepileptic drugs: new therapeutic options].
    Baulac M
    Rev Neurol (Paris); 2002 May; 158(5 Pt 2):4S46-54. PubMed ID: 11997751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zonisamide in the management of epilepsy--Japanese experience.
    Ohtahara S
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S25-33. PubMed ID: 16321507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.